ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) Stock Price & Overview
OSL:AZT • NO0010014632
Current stock price
The current stock price of AZT.OL is 19.625 NOK. Today AZT.OL is down by -0.38%. In the past month the price decreased by -8.37%. In the past year, price increased by 15.88%.
AZT.OL Key Statistics
- Market Cap
- 1.002B
- P/E
- 103.29
- Fwd P/E
- 47.39
- EPS (TTM)
- 0.19
- Dividend Yield
- N/A
AZT.OL Stock Performance
AZT.OL Stock Chart
AZT.OL Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to AZT.OL. When comparing the yearly performance of all stocks, AZT.OL is a bad performer in the overall market: 61.87% of all stocks are doing better.
AZT.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to AZT.OL. AZT.OL has an excellent financial health rating, but there are some minor concerns on its profitability.
AZT.OL Earnings
On February 12, 2026 AZT.OL reported an EPS of 0.13 and a revenue of 34.66M. The company beat EPS expectations (157.43% surprise) and beat revenue expectations (12.5% surprise).
AZT.OL Forecast & Estimates
6 analysts have analysed AZT.OL and the average price target is 34.68 NOK. This implies a price increase of 76.71% is expected in the next year compared to the current price of 19.625.
For the next year, analysts expect an EPS growth of 117.95% and a revenue growth 26.73% for AZT.OL
AZT.OL Groups
Sector & Classification
AZT.OL Financial Highlights
Over the last trailing twelve months AZT.OL reported a non-GAAP Earnings per Share(EPS) of 0.19. The EPS increased by 35.71% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 9.18% | ||
| ROA | 2.86% | ||
| ROE | 3.05% | ||
| Debt/Equity | 0.01 |
AZT.OL Ownership
AZT.OL Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1AE | ARGENX SE | 29.18 | 41.93B | ||
| ARGX | ARGENX SE | 29.62 | 41.893B | ||
| 22UA | BIONTECH SE-ADR | N/A | 21.052B | ||
| ABVX | ABIVAX SA | N/A | 8.31B | ||
| 2X1 | ABIVAX SA | N/A | 8.294B | ||
| GXE | GALAPAGOS NV | N/A | 1.607B | ||
| GLPG | GALAPAGOS NV | N/A | 1.582B | ||
| NANO | NANOBIOTIX | N/A | 1.276B | ||
| PHGN | PHARMING GROUP NV | 48.16 | 1.024B | ||
| PHARM | PHARMING GROUP NV | 48.94 | 1.019B | ||
| DBV | DBV TECHNOLOGIES SA | N/A | 1.007B | ||
| DBV | DBV TECHNOLOGIES SA | N/A | 1.005B | ||
| IVA | INVENTIVA SA | N/A | 916.001M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Oslo Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find more growth stocks the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About AZT.OL
Company Profile
ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
Company Info
IPO: 2005-11-04
ARCTICZYMES TECHNOLOGIES ASA
Sykehusveien 23
Tromso TROMS NO
Employees: 53
Phone: 4777648900
ARCTICZYMES TECHNOLOGIES ASA / AZT.OL FAQ
What does AZT do?
ArcticZymes Technologies ASA is a holding company, which engages in the development, manufacture, and marketing of immunomodulatory products and cold adapted marine enzymes. As a life science company, Arcticzymes Technologies ASA is focused on the development, manufacturing, and commercialization of novel and high-quality recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. Some of the key features of the Company’s enzymes include cold activeness and salt tolerance. The Company’s divided into two operating segments; Enzymes and Corporate. Arcticzymes established logistic hubs in the United States and the Netherlands to serve its customers more efficiently.
What is the current price of AZT stock?
The current stock price of AZT.OL is 19.625 NOK. The price decreased by -0.38% in the last trading session.
Does ARCTICZYMES TECHNOLOGIES ASA pay dividends?
AZT.OL does not pay a dividend.
What is the ChartMill technical and fundamental rating of AZT stock?
AZT.OL has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the analyst forecast for AZT.OL stock?
6 analysts have analysed AZT.OL and the average price target is 34.68 NOK. This implies a price increase of 76.71% is expected in the next year compared to the current price of 19.625.
Can you provide the upcoming earnings date for ARCTICZYMES TECHNOLOGIES ASA?
ARCTICZYMES TECHNOLOGIES ASA (AZT.OL) will report earnings on 2026-05-07.